Navigation Links
Takeda to Acquire Inviragen, Inc.
Date:5/7/2013

) is transmitted via mosquito and can cause fever, headache, fatigue, nausea, vomiting, muscle pain, rash and joint pain in those infected. Approximately 30% of patients showing clinical signs experience incapacitating joint pain, or arthritis that may persist for weeks, months, or in some cases years. On rare occasions, CHIKV infection may lead to neurologic and hepatic disease with high illness and mortality rates. CHIKV is considered endemic in 34 countries in Europe, Australia, Asia and Africa.

About Inviragen, Inc.
Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's vaccine to protect against dengue fever is in Phase 2 clinical testing. A vaccine designed to protect children from hand, foot and mouth disease has completed Phase 1 clinical testing. Vaccines to protect against chikungunya and Japanese encephalitis, which affect millions of individuals in Asia, are in development.  Vaccines in preclinical research stages include vaccines to protect against new forms of influenza and a combination plague/smallpox vaccine for biodefense. Founded in 2005 with offices in Colorado, Wisconsin and Singapore, Inviragen's investors include EDBI (through Bio*One Capital, Singapore), Charter Life Sciences (Sunnyvale, CA), Venture Investors (Madison, WI), and Phillip Private Equity (Singapore). See www.inviragen.com for more details.

About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in '/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Responds to Verdict in Diabetes Drug Case
2. Takeda Launches New Subsidiary in Ecuador
3. Takeda lanza nueva subsidiaria en Ecuador
4. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
5. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
7. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
10. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
11. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... SAN DIEGO , 29 septembre ... désignée Daiichi Sankyo) (TSE : 4568) et Ambit Biosciences ... d,un accord de fusion définitif en vertu duquel ... actions ordinaires en circulation d,Ambit Biosciences à 15 ... d,une offre publique d,achat qui sera suivie d,une ...
(Date:9/29/2014)... 2014  BioMed Realty Trust, Inc. (NYSE: ... lease for approximately 200,000 square feet for 12 years ... Inc., at 650 East Kendall Street in ... Realty through a joint venture with Prudential Real Estate ... and research and development (R&D) center at the site ...
(Date:9/29/2014)... Sept. 29, 2014  Moberg ( www.moberg.com ) ... Monitor, a medical device used for advanced monitoring ... certifies that a product has met European Union ... . The CNS Monitor captures ... or brain waves) to support neurological patient care. ...
Breaking Medicine Technology:Daiichi Sankyo va acquérir Ambit Biosciences 2Daiichi Sankyo va acquérir Ambit Biosciences 3Daiichi Sankyo va acquérir Ambit Biosciences 4Daiichi Sankyo va acquérir Ambit Biosciences 5Daiichi Sankyo va acquérir Ambit Biosciences 6Daiichi Sankyo va acquérir Ambit Biosciences 7Daiichi Sankyo va acquérir Ambit Biosciences 8Daiichi Sankyo va acquérir Ambit Biosciences 9BioMed Realty Trust Signs A New 12-Year Lease Establishing New Innovation And R&D Center In Kendall Square In Cambridge, Massachusetts 2BioMed Realty Trust Signs A New 12-Year Lease Establishing New Innovation And R&D Center In Kendall Square In Cambridge, Massachusetts 3Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2
... June 9, 2011 Reportlinker.com announces that a ... catalogue: South and Central America ... http://www.reportlinker.com/p0548448/South-and-Central-America-Dental-Devices-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Dental_Equipment South and ... Summary GlobalData,s ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: ... second quarter ending June 30, 2011, to approximately $122 million, ... second quarter of 2010, an anticipated one percent year-over-year increase. ... due to a mathematical error. The forecasted growth is primarily ...
Cached Medicine Technology:Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 2Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 3Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 4Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 5Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 6Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 7Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 8Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 9Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 10Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 11Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 12Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017 13PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million 2PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million 3PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million 4
(Date:9/29/2014)... NY (PRWEB) September 30, 2014 ... F.A.A.P., Owner and President of Private Pediatrics of ... the Year. She is recognized for leadership in pediatrics ... largest, most-recognized organization of women in the country, spanning ... Professional Women (NAPW) is a powerfully vibrant networking community ...
(Date:9/29/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... iPage are the most recommended suppliers that provide ... “Our research is based on performance, popularity, feature, ... Justhost and iPage are the most recommended SEO ... have been working in the hosting industry for ...
(Date:9/29/2014)... 2014 Each year over 8 million ... of dizziness and imbalance. Symptoms of vestibular disorders can ... the population range can vary as much as the ... be seeking medical assistance for dizziness and imbalance or ... with post blast or post concussion injuries often have ...
(Date:9/29/2014)... Humility of Mary Health Partners will offer ... D.D. and Velma Davis Family YMCA in Boardman and St. ... to manage their weight by making lifestyle changes with regard ... 5:30 to 6:30 p.m. Wednesdays at the YMCA, 2045 McClurg ... at the Mall (next to the rear entrance to Sears) ...
(Date:9/29/2014)... Rodrigo Guerrero, a Harvard-trained epidemiologist and mayor of Cali, ... a new US$100,000 award for turning evidence into health ... Dr. Guerrero,s success in dramatically reducing the toll of ... one of the most violent in the countryhas influenced ... , The Roux Prize is given by the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Dr. Natalie W. Geary, Owner / President of Private Pediatrics of Palm Beach, a 2014 Professional Woman of the Year 2Health News:Top 10 Best SEO Hosting Recommends GreenGeeks, Justhost And iPage To Webmasters Worldwide 2Health News:North American Seminars Received PT Continuing Education Course Approval in California and Nevada and Illinois for an Online Vestibular Continuing Education Course 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2Health News:Dr. Rodrigo Guerrero wins Roux Prize for using data 2Health News:Dr. Rodrigo Guerrero wins Roux Prize for using data 3Health News:Dr. Rodrigo Guerrero wins Roux Prize for using data 4
... full, study suggests , , MONDAY, June 16 (HealthDay News) -- ... sweeteners may help you feel fuller faster and decrease the ... this may be a new way to help people lose ... can stimulate the sense of taste -- included 2,436 overweight ...
... La.The first patient scans from a custom-built scanner ... (CT) technologies indicate that these scans could significantly ... more targeted treatment options, according to researchers at ... designed to help physicians determine stages of breast ...
... NEW ORLEANS, La.A new study, presented at the ... pre-target the treatment of cancer cellsbringing personalized medicine ... By combining new molecular imaging techniques with targeted ... treatment that can increase the effectiveness of therapies ...
... tomography (PET) and computed tomography (CT) scanning of ... can enable physicians to determine whether the cancer ... to perform surgery, according to researchers at the ... surgeries could be reduced, which would also lower ...
... are developing new technology to create individualised brain maps ... accuracy of brain surgery. , Currently researchers and ... that are based on a small number of individuals, ... differences that can occur between people,s brains. , The ...
... Jersey Hospital, RIDGEWOOD, N.J., June 16 Ridgewood resident,David ... historic charitable contribution to The Valley Hospital in,Ridgewood, NJ. The ... its main campus, is thought to be the largest single ... gift to Valley because I want my giving to do ...
Cached Medicine News:Health News:Flavoring Food May Promote Weight Loss 2Health News:Flavoring Food May Promote Weight Loss 3Health News:New possibilities for breast cancer treatment on the horizon 2Health News:Personalizing medicine: New research shows potential of targeted therapies for cancer 2Health News:PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer 2Health News:Developing unique brain maps to assist surgery and research 2Health News:The Valley Hospital in Ridgewood, NJ, Announces Historic $30 Million Gift 2
... Catalyst system introduces a new ... to microsurgical instrumentation. It has ... design with advanced microcomputer control ... to operate with a full ...
The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....
... Horizon Phacoemulsification System is ... surgical system. Lightweight and ... performance and features in ... also provides all modes ...
Compact ultrasonic phacoemulsification system....
Medicine Products: